- Home
- LIVN vs MGNI Comparison
LIVN vs MGNI Comparison
Compare LIVN & MGNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIVN
- MGNI
- Stock Information
- Founded
- LIVN 1987
- MGNI 2007
- Country
- LIVN United Kingdom
- MGNI United States
- Employees
- LIVN N/A
- MGNI N/A
- Industry
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- MGNI Computer Software: Programming Data Processing
- Sector
- LIVN Health Care
- MGNI Technology
- Exchange
- LIVN Nasdaq
- MGNI Nasdaq
- Market Cap
- LIVN 2.9B
- MGNI 3.1B
- IPO Year
- LIVN 1993
- MGNI N/A
- Fundamental
- Price
- LIVN $57.65
- MGNI $14.26
- Analyst Decision
- LIVN Strong Buy
- MGNI Strong Buy
- Analyst Count
- LIVN 7
- MGNI 11
- Target Price
- LIVN $60.00
- MGNI $26.00
- AVG Volume (30 Days)
- LIVN 599.4K
- MGNI 3.1M
- Earning Date
- LIVN 11-05-2025
- MGNI 11-05-2025
- Dividend Yield
- LIVN N/A
- MGNI N/A
- EPS Growth
- LIVN N/A
- MGNI 219.02
- EPS
- LIVN N/A
- MGNI 0.38
- Revenue
- LIVN $1,348,962,000.00
- MGNI $702,565,000.00
- Revenue This Year
- LIVN $10.10
- MGNI $2.09
- Revenue Next Year
- LIVN $7.90
- MGNI $11.41
- P/E Ratio
- LIVN N/A
- MGNI $37.44
- Revenue Growth
- LIVN 8.63
- MGNI 6.27
- 52 Week Low
- LIVN $32.48
- MGNI $8.22
- 52 Week High
- LIVN $58.91
- MGNI $26.65
- Technical
- Relative Strength Index (RSI)
- LIVN 62.26
- MGNI 26.74
- Support Level
- LIVN $48.82
- MGNI $14.44
- Resistance Level
- LIVN $51.97
- MGNI $15.55
- Average True Range (ATR)
- LIVN 1.86
- MGNI 1.01
- MACD
- LIVN 0.14
- MGNI -0.30
- Stochastic Oscillator
- LIVN 85.96
- MGNI 10.14
About LIVN LivaNova PLC
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
About MGNI Magnite Inc.
Magnite Inc is one of the supply-side platform providers, or SSP, in online advertising. The firm generate its revenue from the programmatic sale of CTV ad inventory, from mobile online sites and apps, and the remaining from websites accessed via computer.